People

Lone Veng

Lone Veng, also identified as Lone Merete Veng in her original2022 interview, is the former CEO of ResoTher Pharma. The issuer’sFebruary1,2023 leadership announcement confirms she led the business since2017 and handed leadership to AndersKronborg, effectiveFebruary1,2023. She led earlypreclinicaldevelopment, researchgrantfunding, theMay2021DKK38.8M private shareissue and first-in-human clinicaldevelopment ofRTP026. The originalOctober25,2022 companyinterview provides an authentic explicitlycaptioned companyportrait. Her role is historical rather than current2026 employment or a personalinvestment.